BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 20, 2010
View Archived Issues
IBAT inhibitor A-3309 improves constipation in double-blind trial
Read More
Menveo protects adults age 56 years and older from meningococcal disease
Read More
Promising preclinical profile of MEK kinase inhibitor TAK-733
Read More
Myriad's candidate anticancer therapeutics inhibit Nampt
Read More
Bayer and AstraZeneca claim new glucocorticoid receptor ligands
Read More
Roche discloses new hepatitis C virus NS5B polymerase inhibitors
Read More
New compounds potentiating the activity of mutant glucosidades
Read More
Vertex claims new CFTR channel modulators
Read More
JAK2 inhibitor TG-AZ1 sensitizes lung cancer cells to radiation
Read More
Odanacatib promising in phase II trial in postmenopausal women with low BMD
Read More
Early indomethacin reduces early atrial fibrillation recurrence after AF ablation
Read More
Brinavess superior to amiodarone for treating atrial fibrillation in phase III trial
Read More
Biogen Idec claims new lysophospholipid S1P1 receptor agonists
Read More
Roche and Biogen Idec discontinue ocrelizumab development in RA
Read More
Kyowa Hakko Kirin announces highlights of first quarter 2010
Read More
FDA approves Stealth Peptides' IND for phase I Bendavia trial
Read More
Vernalis issues management statement
Read More
Lentigen receives NIH grant for gene therapy research in Hunter's syndrome
Read More
NicOx discusses activities in strategic update
Read More
FDA grants priority review to Sigma-Tau's NDA for cysteamine eye drops
Read More
Idebenone misses primary endpoint in phase III trial in Friedreich's ataxia
Read More
FDA approves Zymaxid ophthalmic solution 0.5% for bacterial conjunctivitis
Read More
Oncolytics Biotech to begin phase I ReoT3D trial in colorectal cancer
Read More
NanoViricides and UCSF collaborate to test anti-HIV drug candidates
Read More
U.K. and Spanish regulators recommend Sativex for approval
Read More
Health Canada grants Centocor marketing authorization for Yondelis in ovarian cancer
Read More